Verition Fund Management’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.07M Buy
123,452
+54,252
+78% +$909K 0.01% 1423
2025
Q1
$1.06M Buy
+69,200
New +$1.06M 0.01% 1593
2024
Q4
Hold
0
2790
2024
Q3
Hold
0
2770
2024
Q2
Hold
0
2570
2024
Q1
Hold
0
2337
2023
Q2
Sell
-20,026
Closed -$177K 2249
2023
Q1
$177K Buy
20,026
+2,620
+15% +$23.2K ﹤0.01% 1633
2022
Q4
$159K Sell
17,406
-875
-5% -$7.98K ﹤0.01% 1398
2022
Q3
$148K Sell
18,281
-73,104
-80% -$592K ﹤0.01% 1955
2022
Q2
$687K Buy
+91,385
New +$687K 0.01% 1203
2022
Q1
Sell
-32,986
Closed -$264K 2238
2021
Q4
$264K Buy
+32,986
New +$264K ﹤0.01% 1433
2021
Q3
Sell
-11,999
Closed -$119K 2034
2021
Q2
$119K Buy
+11,999
New +$119K ﹤0.01% 1561
2020
Q1
Sell
-40,383
Closed -$396K 928
2019
Q4
$396K Buy
40,383
+6,625
+20% +$65K 0.01% 647
2019
Q3
$232K Buy
33,758
+12,461
+59% +$85.6K 0.01% 781
2019
Q2
$197K Sell
21,297
-77,136
-78% -$714K 0.01% 890
2019
Q1
$1.54M Buy
+98,433
New +$1.54M 0.06% 247
2018
Q4
Sell
-113,217
Closed -$2.44M 1160
2018
Q3
$2.44M Buy
+113,217
New +$2.44M 0.09% 215
2018
Q1
Sell
-10,300
Closed -$195K 1251
2017
Q4
$195K Sell
10,300
-62,006
-86% -$1.17M 0.02% 768
2017
Q3
$1.27M Sell
72,306
-290
-0.4% -$5.11K 0.1% 197
2017
Q2
$2.41M Sell
72,596
-26,591
-27% -$883K 0.23% 55
2017
Q1
$3.18M Buy
99,187
+75,435
+318% +$2.42M 0.3% 35
2016
Q4
$861K Sell
23,752
-13,158
-36% -$477K 0.07% 279
2016
Q3
$1.7M Buy
36,910
+7,445
+25% +$342K 0.18% 82
2016
Q2
$1.48M Buy
29,465
+17,020
+137% +$855K 0.19% 95
2016
Q1
$666K Buy
+12,445
New +$666K 0.11% 212
2015
Q4
Sell
-9,485
Closed -$536K 580
2015
Q3
$536K Buy
+9,485
New +$536K 0.14% 175